International Patent: BISPECIFIC POLYPEPTIDES TARGETING INTERLEUKIN 1 BETA AND TYPE II COLLAGEN AND METHODS OF USING THE SAME

GENEVA, Aug. 7 -- AVALOR THERAPEUTICS, INC. filed a patent application (US2026/013244) for “BISPECIFIC POLYPEPTIDES TARGETING INTERLEUKIN 1 BETA AND TYPE II COLLAGEN AND METHODS OF USING THE SAME”. With publication no. WO/2026/165340, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....